MedPharm Research, a subsidiary of MedPharm Holdings, has obtained a Schedule I Researcher License from the Drug Enforcement Administration, enabling them to possess and use Schedule I substances for research purposes, including shipping investigational medications for clinical trials over state lines, as well as study all of the over 400 molecules known to be made by the cannabis plant.

Iowa has expanded its medical marijuana program to include patients with Post Traumatic Stress Disorder and Severe Autism, but some Democrats and industry experts said the THC level allowed is not enough to help severe health conditions. MedPharm, the company that runs Iowa's CBD dispensaries, said it is not happy with the new THC limit and will continue to push for higher levels in the next legislative session.

Iowa's first medical cannabis dispensary has opened in Windsor Heights and one of the first patients to be treated is Terri Clark, who suffers from chronic pain after a car accident, and with a registration card for cannabidiol, she will try drops to see if they can replace her current opioid prescription.

Former Iowa Governor Terry Branstad signed a bill in May 2017 expanding Iowa's limited medical marijuana program to include patients suffering from a list of debilitating conditions including cancer, multiple sclerosis, seizures, AIDS, Crohn's disease and Amyotrophic Lateral Sclerosis (ALS).

The market really kicked off in Iowa, December 1st, 2018 – and from there we’ve been able to supply products to the various dispensaries across the state, from then.  We’ve gone through a lot of changes.  We’ve been able to remove a THC cap that used to be on the program.  Now, allowing fully THC levels in any of the products.